Works matching DE "OSTEOPOROSIS drugs"

Results: 134

Bone-Modifying Agents as Adjuvant Therapy for Early-Stage Breast Cancer.

Published in:

Oncology (08909091), 2012, v. 26, n. 10, p. 955

By:

Figueroa-Magalhães, Maria Cristina;
Miller, Robert S.

Publication type:

Article

Persistence and adherence to parenteral osteoporosis therapies: a systematic review.

Published in:

Osteoporosis International, 2020, v. 31, n. 11, p. 2093, doi. 10.1007/s00198-020-05507-9

By:

Koller, G.;
Goetz, V.;
Vandermeer, B.;
Homik, J.;
McAlister, F. A.;
Kendler, D.;
Ye, C.

Publication type:

Article

Racial difference in bioavailability of oral ibandronate between Caucasian and Taiwanese postmenopausal women.

Published in:

Osteoporosis International, 2020, v. 31, n. 1, p. 193, doi. 10.1007/s00198-019-05127-y

By:

Chiu, W.-Y.;
Lin, C.-J.;
Yang, W.-S.;
Tsai, K.-S.;
Reginster, J.-Y.

Publication type:

Article

Comparison of the efficacy between once-monthly oral ibandronate and risedronate among Korean women with osteoporosis: a nationwide population-based study.

Published in:

Osteoporosis International, 2019, v. 30, n. 3, p. 659, doi. 10.1007/s00198-018-4778-0

By:

Lee, Dong Ryul;
Lee, Jungun

Publication type:

Article

Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density.

Published in:

Osteoporosis International, 2018, v. 29, n. 6, p. 1407, doi. 10.1007/s00198-018-4460-6

By:

Naylor, K. E.;
Paggiosi, M. A.;
Gossiel, F.;
Walsh, J. S.;
Eastell, R.;
McCloskey, E. V.;
Bradburn, M.;
Peel, N. F. A.

Publication type:

Article

Factors associated with acute-phase response of bisphosphonate-naïve or pretreated women with osteoporosis receiving an intravenous first dose of zoledronate or ibandronate.

Published in:

Osteoporosis International, 2017, v. 28, n. 6, p. 1995, doi. 10.1007/s00198-017-3992-5

By:

Popp, A.W.;
Senn, R.;
Curkovic, I.;
Senn, C.;
Buffat, H.;
Popp, P.F.;
Lippuner, K.

Publication type:

Article

Retreatment with teriparatide: our experience in three patients with severe secondary osteoporosis.

Published in:

Osteoporosis International, 2017, v. 28, n. 4, p. 1491, doi. 10.1007/s00198-016-3869-z

By:

Mana, D.;
Zanchetta, M.;
Zanchetta, J.

Publication type:

Article

Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years.

Published in:

Osteoporosis International, 2017, v. 28, n. 4, p. 1355, doi. 10.1007/s00198-016-3886-y

By:

Modi, A.;
Sajjan, S.;
Insinga, R.;
Weaver, J.;
Lewiecki, E.;
Harris, S.

Publication type:

Article

Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses.

Published in:

Osteoporosis International, 2016, v. 27, n. 11, p. 3289, doi. 10.1007/s00198-016-3654-z

By:

Zhou, J.;
Ma, X.;
Wang, T.;
Zhai, S.

Publication type:

Article

GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab.

Published in:

Osteoporosis International, 2016, v. 27, n. 10, p. 2967, doi. 10.1007/s00198-016-3623-6

By:

Hadji, P.;
Kyvernitakis, I.;
Kann, P.;
Niedhart, C.;
Hofbauer, L.;
Schwarz, H.;
Kurth, A.;
Thomasius, F.;
Schulte, M.;
Intorcia, M.;
Psachoulia, E.;
Schmid, T.

Publication type:

Article

Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study.

Published in:

Osteoporosis International, 2016, v. 27, n. 1, p. 21, doi. 10.1007/s00198-015-3145-7

By:

Naylor, K.;
Jacques, R.;
Paggiosi, M.;
Gossiel, F.;
Peel, N.;
McCloskey, E.;
Walsh, J.;
Eastell, R.

Publication type:

Article

Bone turnover markers: response to comments by Seeman and Nguyen.

Published in:

2016

By:

Naylor, K.;
Jacques, R.;
Paggiosi, M.;
Gossiel, F.;
Peel, N.;
McCloskey, E.;
Walsh, J.;
Eastell, R.

Publication type:

Letter

Bone remodeling markers: so easy to measure, so difficult to interpret.

Published in:

2016

By:

Seeman, E.;
Nguyen, T.

Publication type:

Letter

Clinical efficacy and safety of monthly oral ibandronate 100 mg versus monthly intravenous ibandronate 1 mg in Japanese patients with primary osteoporosis.

Published in:

Osteoporosis International, 2015, v. 26, n. 11, p. 2685, doi. 10.1007/s00198-015-3175-1

By:

Nakamura, T.;
Ito, M.;
Hashimoto, J.;
Shinomiya, K.;
Asao, Y.;
Katsumata, K.;
Hagino, H.;
Inoue, T.;
Nakano, T.;
Mizunuma, H.

Publication type:

Article

Effect of ibandronate therapy on serum homocysteine and leptin in postmenopausal osteoporotic females.

Published in:

Osteoporosis International, 2015, v. 26, n. 3, p. 1187, doi. 10.1007/s00198-014-2909-9

By:

Tariq, S.;
Alam, S.;
Baig, M.

Publication type:

Article

Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study.

Published in:

Osteoporosis International, 2014, v. 25, n. 12, p. 2729, doi. 10.1007/s00198-014-2817-z

By:

Paggiosi, M.;
Peel, N.;
McCloskey, E.;
Walsh, J.;
Eastell, R.

Publication type:

Article

Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.

Published in:

Osteoporosis International, 2014, v. 25, n. 7, p. 1945, doi. 10.1007/s00198-014-2703-8

By:

Senn, C.;
Günther, B.;
Popp, A.;
Perrelet, R.;
Hans, D.;
Lippuner, K.

Publication type:

Article

Effect of Strontium Ranelate on Condylar Growth during Mandibular Advancement in Rats.

Published in:

Turkish Journal of Orthodontics, 2020, v. 33, n. 4, p. 216, doi. 10.5152/TurkJOrthod.2020.20014

By:

Camcı, Hasan;
Doruk, Cenk;
Saraydın, Serpil Ünver

Publication type:

Article

The Effect of Alendronate on Proteome of Hepatocellular Carcinoma Cell Lines.

Published in:

International Journal of Proteomics, 2014, p. 1, doi. 10.1155/2014/532953

By:

Ilyas, Amber;
Hashim, Zehra;
Naeem, Nadia;
Haneef, Kanwal;
Zarina, Shamshad

Publication type:

Article

Avaliação Radiográfica e Histomorfométrica da Mandíbula de Ratas Medicadas com Glicocorticóide e Bifosfonato.

Published in:

Revista da Faculdade de Odontologia, 2009, v. 50, n. 1, p. 16, doi. 10.22456/2177-0018.5906

By:

Mahl, Celia Regina Winck;
da Fontoura, Fernanda Goulart;
Borelli, Priscilla Vendramini;
da Silva, Isabel Lauxen;
Fontanella, Vania

Publication type:

Article

Treatment failure in osteoporosis.

Published in:

Menopause International, 2012, v. 18, n. 4, p. 125, doi. 10.1258/mi.2012.012038

By:

Brown, Simon

Publication type:

Article

Association Between Antiosteoporotic Drugs and Risk of Acute Kidney Injury: A Cross‐Sectional Study Using Disproportional Analysis and a Pharmacovigilance Database.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 11, p. 1419, doi. 10.1002/jcph.2091

By:

Mitsuboshi, Satoru;
Kaseda, Ryohei;
Narita, Ichiei

Publication type:

Article

Actonel on PBS.

Published in:: Australian Journal of Pharmacy, 2011, v. 92, n. 1095, p. 48
Publication type:: Article

Potential first-in-class osteoporosis drug speeds through trials.

Published in:

Nature Medicine, 2012, v. 18, n. 8, p. 1158, doi. 10.1038/nm0812-1158

By:

Williams, Sarah C P

Publication type:

Article

Acute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case report.

Published in:

2016

By:

Yiming Tian;
Rui Wang;
Lianyuan Liu;
Chunming Ma;
Qiang Lu;
Fuzai Yin;
Tian, Yiming;
Wang, Rui;
Liu, Lianyuan;
Ma, Chunming;
Lu, Qiang;
Yin, Fuzai

Publication type:

journal article

Orthesenversorgung bei Osteoporose und osteoporotischen Wirbelkörperfrakturen.

Published in:

Der Orthopäde, 2010, v. 39, n. 4, p. 387, doi. 10.1007/s00132-010-1596-2

By:

Matussek, J.;
Boluki, D.;
Füssel, S.;
Grifka, J.

Publication type:

Article

Organocatalytic Enantioselective Epoxidation of Some Aryl-Substituted Vinylidenebisphosphonate Esters: On the Way to Chiral Anti-Osteoporosis Drugs.

Published in:

Catalysts (2073-4344), 2017, v. 7, n. 3, p. 90, doi. 10.3390/catal7030090

By:

Chiminazzo, Andrea;
Sperni, Laura;
Scarso, Alessandro;
Strukul, Giorgio

Publication type:

Article

Bisphosphonate treatment in children with acute lymphoblastic leukemia and osteonecrosis – radiological and clinical findings in a national cohort.

Published in:

Acta Oncologica, 2021, v. 60, n. 9, p. 1140, doi. 10.1080/0284186X.2021.1950928

By:

Utriainen, Pauliina;
Niinimäki, Tuukka T.;
Huurre, Anu J.;
Vepsäläinen, Kaisa L.;
Mäkitie, Outi M.;
Niinimäki, Riitta A.

Publication type:

Article

Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines.

Published in:

Acta Oncologica, 2011, v. 50, n. 1, p. 127, doi. 10.3109/0284186X.2010.482103

By:

Epplen, Robin;
Stöckle, Michael;
Engelmann, Udo;
Heidenreich, Axel;
Ohlmann, Carsten-Henning

Publication type:

Article

Patterns of Anti-Osteoporosis Medication Use among Women at High Risk of Fracture: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).

Published in:

PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082840

By:

Gehlbach, Stephen;
Hooven, Frederick H.;
Wyman, Allison;
Diez-Perez, Adolfo;
Adachi, Jonathan D.;
Luo, Xuemei;
Bushmakin, Andrew G.;
Anderson, Frederick A.

Publication type:

Article

Bisphosphonates: A Once-Yearly Treatment Option with Reclast.

Published in:

South Dakota Medicine, 2008, p. 416

By:

Van Gilder, Deidra

Publication type:

Article

Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures -- a case report.

Published in:

2011

By:

Puah, Ken Lee;
Tan, Mann Hong

Publication type:

Case Study

Evaluation of pain, quality of life, and patient satisfaction in parenterally treated patients with postmenopausal osteoporosis.

Published in:

Turkish Journal of Physical Medicine & Rehabilitation (2587-1250), 2020, v. 66, n. 3, p. 262, doi. 10.5606/tftrd.2020.4114

By:

Özsoy-Ünübol, Tuğba;
Akyüz, Gülseren;
Mirzayeva, Samaya;
Güler, Tuba

Publication type:

Article

Marketing disease: is osteoporosis an example of 'disease mongering'?

Published in:

British Journal of Nursing, 2009, v. 18, n. 17, p. 1064, doi. 10.12968/bjon.2009.18.17.44163

By:

Wright, Jane

Publication type:

Article

Upper gastrointestinal safety and tolerability of oral alendronate: A meta-analysis.

Published in:

Experimental & Therapeutic Medicine, 2016, v. 11, n. 1, p. 289, doi. 10.3892/etm.2015.2848

By:

MANRU ZHOU;
YAYUAN ZHENG;
JIN LI;
JINGKAI WU;
WEIMING XU;
LIAO CUI;
WEIMIN YAO;
YUYU LIU

Publication type:

Article

Clinical trial: comparison of alendronate and alfacalcidol in glucocorticoid-associated osteoporosis in patients with ulcerative colitis.

Published in:

Alimentary Pharmacology & Therapeutics, 2009, v. 29, n. 4, p. 424, doi. 10.1111/j.1365-2036.2008.03899.x

By:

KITAZAKI, S.;
MITSUYAMA, K.;
MASUDA, J.;
HARADA, K.;
YAMASAKI, H.;
KUWAKI, K.;
TAKEDATSU, H.;
SUGIYAMA, G.;
TSURUTA, O.;
SATA, M.

Publication type:

Article

Effect of alendronate on bone remodeling around implant in the rat.

Published in:

Journal of Advanced Prosthodontics, 2013, v. 5, n. 4, p. 374, doi. 10.4047/jap.2013.5.4.374

By:

Ran Park;
Jee-Hwan Kim;
Hyunmin Choi;
Young-Bum Park;
Han-Sung Jung;
Hong-Seok Moon

Publication type:

Article

A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis.

Published in:

PharmacoEconomics, 2015, v. 33, n. 3, p. 205, doi. 10.1007/s40273-014-0231-1

By:

Hiligsmann, Mickaël;
Evers, Silvia;
Ben Sedrine, Wafa;
Kanis, John;
Ramaekers, Bram;
Reginster, Jean-Yves;
Silverman, Stuart;
Wyers, Caroline;
Boonen, Annelies

Publication type:

Article

Efficacy of Teriparatide in Patients with Hypoparathyroidism: A Prospective, Open-label Study.

Published in:

Indian Journal of Endocrinology & Metabolism, 2017, v. 21, n. 3, p. 415, doi. 10.4103/ijem.IJEM_340_16

By:

Upreti, Vimal;
Somani, Shrikant;
Kotwal, Narendra

Publication type:

Article

Sequential therapy: the way to go to prevent fragility fractures.

Published in:

Clinical Cases in Mineral & Bone Metabolism, 2018, v. 15, n. 1, p. 66

By:

Gonnelli, Stefano;
Alessandri, Mario;
Caffarelli, Carla

Publication type:

Article

Appropriate use of anabolic treatment for severe osteoporosis.

Published in:

Clinical Cases in Mineral & Bone Metabolism, 2010, v. 7, n. 2, p. 114

By:

Adami, Silvano;
Brandi, Maria Luisa;
Canonico, Pier Luigi;
Minisola, Giovanni;
Minisola, Salvatore;
Tarantino, Umberto

Publication type:

Article

From the Editor-in-Chief.

Published in:

Clinical Cases in Mineral & Bone Metabolism, 2010, v. 7, n. 1, p. 9

By:

Brandi, Maria Luisa

Publication type:

Article

Efficacy of ibandronate: a long term confirmation.

Published in:

Clinical Cases in Mineral & Bone Metabolism, 2010, v. 7, n. 1, p. 23

By:

Di Munno, Ombretta;
Sedie, Andrea Delle

Publication type:

Article

Risedronate's efficacy: from randomized clinical trials to real clinical practice.

Published in:

Clinical Cases in Mineral & Bone Metabolism, 2010, v. 7, n. 1, p. 19

By:

Iolascon, Giovanni;
Sirico, Felice;
Ferrante, Alberto;
Gimigliano, Raffaele;
Gimigliano, Francesca

Publication type:

Article

Effect of Alendronate with β - TCP Bone Substitute in Surgical Therapy of Periodontal Intra-Osseous Defects: A Randomized Controlled Clinical Trial.

Published in:

Journal of Clinical & Diagnostic Research, 2016, v. 10, n. 8, p. 113, doi. 10.7860/JCDR/2016/20965.8365

By:

NAINENI, ROHINI;
RAVI, VISHALI;
SUBBARAYA, DWIJENDRA KOCHERLAKOTA;
PRASANNA, JAMMULA SURYA;
PANTHULA, VEERENDRANATH REDDY;
KODUGANTI, REKHA RANI

Publication type:

Article

First-Line Medications for Osteoporosis.

Published in:

MEDSURG Nursing, 2019, v. 28, n. 6, p. 381

By:

Felicilda-Reynaldo, Rhea Faye D.

Publication type:

Article

Anti-Osteoporotic Drugs and Vascular Calcification: The Bidirectional Calcium Traffic.

Published in:

Journal of Vascular Research, 2014, v. 51, n. 1, p. 37, doi. 10.1159/000355204

By:

Yavropoulou, Maria P.;
Pikilidou, Maria;
Yovos, John G.

Publication type:

Article

Activation of FGF Receptors is a new Mechanism by which Strontium Ranelate Induces Osteoblastic Cell Growth.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2011, v. 27, n. 3/4, p. 243, doi. 10.1159/000327950

By:

Caverzasio, Joseph;
Thouverey, Cyril

Publication type:

Article

Patent watch.

Published in:

Nature Reviews Drug Discovery, 2012, v. 11, n. 12, p. 898, doi. 10.1038/nrd3912

By:

Harrison, Charlotte

Publication type:

Article

Approaching the ideal selective estrogen receptor modulator for prevention and treatment of postmenopausal osteoporosis.

Published in:: Formulary, 2010, v. 45, n. 2, p. 52
Publication type:: Article